Skip to main content

Market Overview

Why Are Jaguar Health Shares Surging Today?

  • Continuing Friday's rally, Jaguar Health Inc (NASDAQ: JAGX) stock has surged on Monday as the investors react to the news of its third royalty financing agreement announced on Friday.
  • The company entered a binding term sheet for $5 million a royalty interest in future potential crofelemer (Mytesi) sales for the proposed COVID-related indication in long-hauler patients.
  • JAGX is currently pursuing conditional marketing authorization in the European Union.
  • This financing follows two royalty transactions, including $5 million announced in October and $6 million finalized in December.
  • Price Action: On the last check, JAGX surged 48.8% at $2.39 in market trading hours.

Related Articles (JAGX)

View Comments and Join the Discussion!

Posted-In: Covid-19Biotech News Penny Stocks Health Care Financing FDA General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at